|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 981 for Braf

0.063s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Publication
First Author: Yuan P
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma.
Volume: 110
Issue: 45
Pages: 18226-31
Publication
First Author: Berres ML
Year: 2014
Journal: J Exp Med
Title: BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.
Volume: 211
Issue: 4
Pages: 669-83
Publication
First Author: Bosso G
Year: 2022
Journal: Cell Death Dis
Title: Early differential responses elicited by BRAFV600E in adult mouse models.
Volume: 13
Issue: 2
Pages: 142
Publication    
First Author: Urtatiz O
Year: 2021
Journal: Elife
Title: Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma.
Volume: 10
Publication
First Author: Mann MB
Year: 2015
Journal: Nat Genet
Title: Transposon mutagenesis identifies genetic drivers of Braf(V600E) melanoma.
Volume: 47
Issue: 5
Pages: 486-95
Publication
First Author: Peng W
Year: 2016
Journal: Cancer Discov
Title: Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.
Volume: 6
Issue: 2
Pages: 202-16
Publication  
First Author: Le HH
Year: 2021
Journal: EBioMedicine
Title: Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells.
Volume: 73
Pages: 103646
Publication      
First Author: Urtatiz1 O
Year: 2021
Journal: bioRxiv
Title: Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma.
Publication    
First Author: Raguz J
Year: 2016
Journal: Elife
Title: Epidermal RAF prevents allergic skin disease.
Volume: 5
Publication
First Author: van Tuyn J
Year: 2017
Journal: J Invest Dermatol
Title: Oncogene-Expressing Senescent Melanocytes Up-Regulate MHC Class II, a Candidate Melanoma Suppressor Function.
Volume: 137
Issue: 10
Pages: 2197-2207
Publication
First Author: Brighton HE
Year: 2018
Journal: Cancer Res
Title: New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging.
Volume: 78
Issue: 2
Pages: 542-557
Publication
First Author: Shimamura M
Year: 2018
Journal: PLoS One
Title: Mouse models of sporadic thyroid cancer derived from BRAFV600E alone or in combination with PTEN haploinsufficiency under physiologic TSH levels.
Volume: 13
Issue: 8
Pages: e0201365
Publication
First Author: Pritchard CA
Year: 2004
Journal: Mol Cell Biol
Title: B-Raf acts via the ROCKII/LIMK/cofilin pathway to maintain actin stress fibers in fibroblasts.
Volume: 24
Issue: 13
Pages: 5937-52
Publication
First Author: Rai TS
Year: 2014
Journal: Genes Dev
Title: HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of neoplasia.
Volume: 28
Issue: 24
Pages: 2712-25
Publication
First Author: Wojnowski L
Year: 1997
Journal: Nat Genet
Title: Endothelial apoptosis in Braf-deficient mice.
Volume: 16
Issue: 3
Pages: 293-7
Publication
First Author: Vial J
Year: 2019
Journal: Cell Death Differ
Title: The Ectodysplasin receptor EDAR acts as a tumor suppressor in melanoma by conditionally inducing cell death.
Volume: 26
Issue: 3
Pages: 443-454
Publication
First Author: Long JE
Year: 2019
Journal: Cell Death Differ
Title: Therapeutic resistance and susceptibility is shaped by cooperative multi-compartment tumor adaptation.
Volume: 26
Issue: 11
Pages: 2416-2429
Publication
First Author: Lui JW
Year: 2019
Journal: J Cancer
Title: The Efficiency of Verteporfin as a Therapeutic Option in Pre-Clinical Models of Melanoma.
Volume: 10
Issue: 1
Pages: 1-10
Publication
First Author: Luo X
Year: 2014
Journal: Cell Rep
Title: Isolation and molecular characterization of circulating melanoma cells.
Volume: 7
Issue: 3
Pages: 645-53
Publication
First Author: Pandita A
Year: 2021
Journal: Am J Pathol
Title: Intussusceptive Angiogenesis in Human Metastatic Malignant Melanoma.
Volume: 191
Issue: 11
Pages: 2023-2038
Publication
First Author: Muinonen-Martin AJ
Year: 2014
Journal: PLoS Biol
Title: Melanoma cells break down LPA to establish local gradients that drive chemotactic dispersal.
Volume: 12
Issue: 10
Pages: e1001966
Publication
First Author: Le Gal K
Year: 2015
Journal: Sci Transl Med
Title: Antioxidants can increase melanoma metastasis in mice.
Volume: 7
Issue: 308
Pages: 308re8
Publication
First Author: Hölzel M
Year: 2016
Journal: Cancer Res
Title: A Preclinical Model of Malignant Peripheral Nerve Sheath Tumor-like Melanoma Is Characterized by Infiltrating Mast Cells.
Volume: 76
Issue: 2
Pages: 251-63
Publication
First Author: Chen S
Year: 2017
Journal: Nature
Title: Palmitoylation-dependent activation of MC1R prevents melanomagenesis.
Volume: 549
Issue: 7672
Pages: 399-403
Publication
First Author: Blair LM
Year: 2023
Journal: Nat Commun
Title: Oncogenic context shapes the fitness landscape of tumor suppression.
Volume: 14
Issue: 1
Pages: 6422
Publication
First Author: Kamata T
Year: 2017
Journal: Blood
Title: KRASG12D expression in lung-resident myeloid cells promotes pulmonary LCH-like neoplasm sensitive to statin treatment.
Volume: 130
Issue: 4
Pages: 514-526
Publication  
First Author: Rodríguez CI
Year: 2018
Journal: Cancer Lett
Title: Elevated cyclic AMP levels promote BRAFCA/Pten-/- mouse melanoma growth but pCREB is negatively correlated with human melanoma progression.
Volume: 414
Pages: 268-277
Publication
First Author: Spitzer MH
Year: 2017
Journal: Cell
Title: Systemic Immunity Is Required for Effective Cancer Immunotherapy.
Volume: 168
Issue: 3
Pages: 487-502.e15
Publication
First Author: Zhai Y
Year: 2020
Journal: Pigment Cell Melanoma Res
Title: Differences in tumor initiation and progression of melanoma in the BrafCA ;Tyr-CreERT2;Ptenf/f model between male and female mice.
Volume: 33
Issue: 1
Pages: 119-121
Publication
First Author: Zhao F
Year: 2018
Journal: Cancer Immunol Res
Title: Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGFβ Inhibitor Sequencing in Melanoma.
Volume: 6
Issue: 12
Pages: 1459-1471
Publication
First Author: Rodríguez CI
Year: 2017
Journal: Mol Cancer Res
Title: EPAC-RAP1 Axis-Mediated Switch in the Response of Primary and Metastatic Melanoma to Cyclic AMP.
Volume: 15
Issue: 12
Pages: 1792-1802
Publication  
First Author: Deken MA
Year: 2016
Journal: Int J Mol Sci
Title: Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in PtenLoxP/LoxP;BrafCA/+ Mice.
Volume: 17
Issue: 12
Publication
First Author: Hooijkaas AI
Year: 2012
Journal: Am J Pathol
Title: Targeting BRAFV600E in an inducible murine model of melanoma.
Volume: 181
Issue: 3
Pages: 785-94
Publication
First Author: Couto JP
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: STAT3 negatively regulates thyroid tumorigenesis.
Volume: 109
Issue: 35
Pages: E2361-70
Publication
First Author: Rzasa P
Year: 2023
Journal: Commun Biol
Title: BRAF(V600E)-mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism.
Volume: 6
Issue: 1
Pages: 962
Publication
First Author: Knauf JA
Year: 2005
Journal: Cancer Res
Title: Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation.
Volume: 65
Issue: 10
Pages: 4238-45
Publication
First Author: Hong SW
Year: 2012
Journal: J Biol Chem
Title: Ring finger protein 149 is an E3 ubiquitin ligase active on wild-type v-Raf murine sarcoma viral oncogene homolog B1 (BRAF).
Volume: 287
Issue: 28
Pages: 24017-25
Publication
First Author: Rizq O
Year: 2023
Journal: Leukemia
Title: UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease.
Volume: 37
Issue: 9
Pages: 1895-1907
Publication
First Author: Niault TS
Year: 2010
Journal: Carcinogenesis
Title: Targets of Raf in tumorigenesis.
Volume: 31
Issue: 7
Pages: 1165-74
Publication
First Author: Charles RP
Year: 2011
Journal: Cancer Res
Title: Mutationally activated BRAF(V600E) elicits papillary thyroid cancer in the adult mouse.
Volume: 71
Issue: 11
Pages: 3863-71
Publication
First Author: Tsukamoto H
Year: 2008
Journal: Eur J Immunol
Title: B-Raf-mediated signaling pathway regulates T cell development.
Volume: 38
Issue: 2
Pages: 518-27
Publication
First Author: Ni TK
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Low-copy piggyBac transposon mutagenesis in mice identifies genes driving melanoma.
Volume: 110
Issue: 38
Pages: E3640-9
Publication
First Author: Gualtieri A
Year: 2021
Journal: Nat Commun
Title: Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humans.
Volume: 12
Issue: 1
Pages: 2028
Publication
First Author: Knauf JA
Year: 2011
Journal: Oncogene
Title: Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling.
Volume: 30
Issue: 28
Pages: 3153-62
Publication
First Author: Shurin GV
Year: 2019
Journal: Cancer Res
Title: Melanoma-Induced Reprogramming of Schwann Cell Signaling Aids Tumor Growth.
Volume: 79
Issue: 10
Pages: 2736-2747
Publication
First Author: Shinzawa K
Year: 2023
Journal: Oncogene
Title: GREB1 isoform 4 is specifically transcribed by MITF and required for melanoma proliferation.
Volume: 42
Issue: 42
Pages: 3142-3156
Publication
First Author: Boussouar A
Year: 2020
Journal: Cancer Res
Title: Netrin-1 and Its Receptor DCC Are Causally Implicated in Melanoma Progression.
Volume: 80
Issue: 4
Pages: 747-756
Publication
First Author: Xu M
Year: 2018
Journal: Clin Cancer Res
Title: Copper Chelation as Targeted Therapy in a Mouse Model of Oncogenic BRAF-Driven Papillary Thyroid Cancer.
Volume: 24
Issue: 17
Pages: 4271-4281
Publication
First Author: Vittoria MA
Year: 2022
Journal: Nat Commun
Title: Inactivation of the Hippo tumor suppressor pathway promotes melanoma.
Volume: 13
Issue: 1
Pages: 3732
Publication
First Author: Kondo J
Year: 2020
Journal: J Pathol
Title: A smooth muscle-derived, Braf-driven mouse model of gastrointestinal stromal tumor (GIST): evidence for an alternative GIST cell-of-origin.
Volume: 252
Issue: 4
Pages: 441-450
Publication
First Author: Xie X
Year: 2015
Journal: Cancer Discov
Title: Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma.
Volume: 5
Issue: 4
Pages: 410-23
Publication
First Author: Yang J
Year: 2014
Journal: Cancer Res
Title: Myeloid IKKβ promotes antitumor immunity by modulating CCL11 and the innate immune response.
Volume: 74
Issue: 24
Pages: 7274-84
Publication
First Author: Landrette SF
Year: 2011
Journal: PLoS One
Title: piggyBac transposon somatic mutagenesis with an activated reporter and tracker (PB-SMART) for genetic screens in mice.
Volume: 6
Issue: 10
Pages: e26650
Publication
First Author: Riedel A
Year: 2016
Journal: Nat Immunol
Title: Tumor-induced stromal reprogramming drives lymph node transformation.
Volume: 17
Issue: 9
Pages: 1118-27
Publication
First Author: Andreadi C
Year: 2012
Journal: Genes Dev
Title: The intermediate-activity (L597V)BRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF/MEK/ERK pathway.
Volume: 26
Issue: 17
Pages: 1945-58
Publication
First Author: Zou M
Year: 2015
Journal: Lab Invest
Title: KRAS(G12D)-mediated oncogenic transformation of thyroid follicular cells requires long-term TSH stimulation and is regulated by SPRY1.
Volume: 95
Issue: 11
Pages: 1269-77
Publication
First Author: Liu S
Year: 2018
Journal: Nat Commun
Title: Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis.
Volume: 9
Issue: 1
Pages: 5426
Publication
First Author: Erkes DA
Year: 2017
Journal: J Immunol
Title: Virus-Specific CD8+ T Cells Infiltrate Melanoma Lesions and Retain Function Independently of PD-1 Expression.
Volume: 198
Issue: 7
Pages: 2979-2988
Publication
First Author: Kohlhapp FJ
Year: 2016
Journal: Cell Rep
Title: Non-oncogenic Acute Viral Infections Disrupt Anti-cancer Responses and Lead to Accelerated Cancer-Specific Host Death.
Volume: 17
Issue: 4
Pages: 957-965
Publication
First Author: Dankort D
Year: 2009
Journal: Nat Genet
Title: Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.
Volume: 41
Issue: 5
Pages: 544-52
Publication
First Author: Galabova-Kovacs G
Year: 2008
Journal: J Cell Biol
Title: Essential role of B-Raf in oligodendrocyte maturation and myelination during postnatal central nervous system development.
Volume: 180
Issue: 5
Pages: 947-55
Publication
First Author: Zanucco E
Year: 2014
Journal: J Biol Chem
Title: Elimination of B-RAF in oncogenic C-RAF-expressing alveolar epithelial type II cells reduces MAPK signal intensity and lung tumor growth.
Volume: 289
Issue: 39
Pages: 26804-26816
Publication
First Author: Kamata T
Year: 2015
Journal: EMBO Mol Med
Title: The cholesterol-binding protein NPC2 restrains recruitment of stromal macrophage-lineage cells to early-stage lung tumours.
Volume: 7
Issue: 9
Pages: 1119-37
Publication  
First Author: Hamada K
Year: 2022
Journal: Front Endocrinol (Lausanne)
Title: MIEAP and ATG5 are tumor suppressors in a mouse model of BRAFV600E-positive thyroid cancer.
Volume: 13
Pages: 932754
Publication
First Author: Ran L
Year: 2017
Journal: Cancer Res
Title: ETV1-Positive Cells Give Rise to BRAFV600E -Mutant Gastrointestinal Stromal Tumors.
Volume: 77
Issue: 14
Pages: 3758-3765
Publication
First Author: Brady DC
Year: 2017
Journal: Cancer Res
Title: Copper Chelation Inhibits BRAFV600E-Driven Melanomagenesis and Counters Resistance to BRAFV600E and MEK1/2 Inhibitors.
Volume: 77
Issue: 22
Pages: 6240-6252
Publication
First Author: Katlinskaya YV
Year: 2016
Journal: Cell Rep
Title: Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression.
Volume: 15
Issue: 1
Pages: 171-80
Publication
First Author: Garnett S
Year: 2017
Journal: Oncogene
Title: p53 loss does not permit escape from BrafV600E-induced senescence in a mouse model of lung cancer.
Volume: 36
Issue: 45
Pages: 6325-6335
Publication
First Author: Krishnaswami SR
Year: 2015
Journal: J Invest Dermatol
Title: Fate and plasticity of the epidermis in response to congenital activation of BRAF.
Volume: 135
Issue: 2
Pages: 481-9
Publication
First Author: Young A
Year: 2017
Journal: Cancer Res
Title: Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis.
Volume: 77
Issue: 17
Pages: 4684-4696
Publication  
First Author: Guida E
Year: 2022
Journal: J Cell Sci
Title: MAPK activation drives male and female mouse teratocarcinomas from late primordial germ cells.
Volume: 135
Issue: 8
Publication
First Author: Basu SK
Year: 2018
Journal: Cancer Res
Title: Oncogenic RAS-Induced Perinuclear Signaling Complexes Requiring KSR1 Regulate Signal Transmission to Downstream Targets.
Volume: 78
Issue: 4
Pages: 891-908
Publication
First Author: Valluet A
Year: 2012
Journal: Cell Rep
Title: B-Raf and C-Raf are required for melanocyte stem cell self-maintenance.
Volume: 2
Issue: 4
Pages: 774-80
Publication
First Author: Kern F
Year: 2013
Journal: Oncogene
Title: Essential, non-redundant roles of B-Raf and Raf-1 in Ras-driven skin tumorigenesis.
Volume: 32
Issue: 19
Pages: 2483-92
Publication
First Author: Huillard E
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy.
Volume: 109
Issue: 22
Pages: 8710-5
Publication
First Author: Gagné-Sansfacon J
Year: 2019
Journal: J Pathol
Title: The tyrosine phosphatase Shp-2 confers resistance to colonic inflammation by driving goblet cell function and crypt regeneration.
Volume: 247
Issue: 1
Pages: 135-146
Publication
First Author: Ferretti R
Year: 2016
Journal: Genes Dev
Title: BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistance.
Volume: 30
Issue: 1
Pages: 18-33
Publication
First Author: Hill KS
Year: 2019
Journal: Mol Cancer Res
Title: PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type Melanomas.
Volume: 17
Issue: 2
Pages: 583-593
Publication
First Author: Cesarini V
Year: 2017
Journal: Oncogene
Title: Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo.
Volume: 36
Issue: 31
Pages: 4508-4515
Publication
First Author: Wang J
Year: 2012
Journal: Cancer Res
Title: B-Raf activation cooperates with PTEN loss to drive c-Myc expression in advanced prostate cancer.
Volume: 72
Issue: 18
Pages: 4765-76
Publication
First Author: Le Mercier I
Year: 2014
Journal: Cancer Res
Title: VISTA Regulates the Development of Protective Antitumor Immunity.
Volume: 74
Issue: 7
Pages: 1933-44
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus caroli
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus pahari
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus spretus